1. Home
  2. FBIOP vs BPYPN Comparison

FBIOP vs BPYPN Comparison

Compare FBIOP & BPYPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIOP

Fortress Biotech Inc.

HOLD

Current Price

$13.50

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

BPYPN

Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

HOLD

Current Price

$13.58

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIOP
BPYPN
Founded
N/A
N/A
Country
United States
Bermuda
Employees
101
24000
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBIOP
BPYPN
Price
$13.50
$13.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.5K
21.0K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$11.81
52 Week High
$14.64
$14.88

Technical Indicators

Market Signals
Indicator
FBIOP
BPYPN
Relative Strength Index (RSI) 58.16 43.31
Support Level $6.85 $13.36
Resistance Level $14.64 $13.54
Average True Range (ATR) 0.60 0.24
MACD -0.10 -0.04
Stochastic Oscillator 56.50 20.84

Price Performance

Historical Comparison
FBIOP
BPYPN

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About BPYPN Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

Brookfield Property Partners LP owns, operates, andin North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

Share on Social Networks: